Surgical algorithm for management of HIV lipodystrophy

Plastic and Reconstructive Surgery

Volumn 120, Issue 7, 2007, Pages 1843-1858

  Davison, Steven P ^a   Timpone Jr , Joseph ^a   Hannan, Catherine M ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOGRAFT; CLINICAL ARTICLE; GRAFT SURVIVAL; GYNECOMASTIA; HIV ASSOCIATED LIPODYSTROPHY; HUMAN; LIPOSUCTION; MASTECTOMY; PAROTID GLAND DISEASE; PAROTIDECTOMY; PRIORITY JOURNAL;

ADIPOSE TISSUE; ADULT; ALGORITHMS; BACK; CELLULOSE; DISEASE PROGRESSION; FACE; GYNECOMASTIA; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; LACTIC ACID; LIPECTOMY; MALE; MANNITOL; NECROSIS; PAROTID GLAND; PATIENT SATISFACTION; POLYMERS; RETROSPECTIVE STUDIES; SURGERY, PLASTIC; SURGICAL FLAPS; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HETEROTOPIC;

EID: 37349000980     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.prs.0000267341.14550.a7     Document Type: Article

References (52)

1. Carr, A. A syndrome of peripheral lipodystrophy, hyperlipidemia, and insulin resistance in patients on HIV protease inhibitors. AIDS 12: F51, 1998.
2. Carpenter, C., Fischl, M., Hammer, S., et al. Antiretroviral therapy of HIV infection, 1997: Updated recommendations of the International AIDS Society - USA panel. J.A.M.A. 277: 1962, 1997.
3. Grunfeld, C., and Feingold, K. R. Metabolic disturbance and wasting in the acquired immunodeficiency syndrome. N. Engl. J. Med. 327: 329, 1992.
4. Paton, N. I., Maccallan, D. C., Jebb, S., et al. Longitudinal changes in body composition measured with a variety of methods in patients with AIDS. J. Acquir. Immune Defic. Syndr. 14: 119, 1997.
5. Carr, A. HIV protease inhibitor-related lipodystrophy syndrome. Clin. Infect. Dis. 30: S135, 2000.
6. Viraben, R. Indinavir-associated lipodystrophy. AIDS 12: F37, 1998.
7. Carr, A., Miller, J., Law, M., and Cooper, D. A. A syndrome of lipoatrophy, lactic acidemia, and liver dysfunction associated with HIV nucleoside analog therapy: Contribution to protease inhibitor-related lipodystrophy syndrome. AIDS 14: F25, 2000.
8. Carr, A., Samaras, K., Chisholm, D. J., and Cooper, D. A. Pathogenesis of peripheral lipodystrophy, hyperlipidemia, and insulin resistance. Lancet 351: 1881, 1998.
9. Karon, J. M., Fleming, P. L., Steketee, R. W., and DeCock, K. M. HIV in the United States at the turn of the century. Am. J. Public Health 91: 1060, 2001.
10. CDC. The global HIV/AIDS epidemic, 2001. M.M.W.R. Morb. Mortal Wkly. Rep. 50: 430, 2001.
11. Roubenoff, R., Weiss, L., McDermott, A., et al. A pilot study of exercise training to reduce trunk fat in adults with HIV-associated fat redistribution. AIDS 13: 1373, 1999.
12. Fisher, K. Wasting and lipodystrophy in patients infected with HIV: A practical approach in clinical practice. AIDS Read. 11: 132, 2001.
13. Corcoran, C., and Grinspoon, S. The use of testosterone in the AIDS wasting syndrome. AIDS Clin. Care 11: 25, 1999.
14. Gold, J., and Batterham, M. Nandrolone decanoate: Use in HIV-associated lipodystrophy syndrome: A pilot study (Letter). Int. J. STD AIDS 10: 558, 1999.
15. Hengge, U. R., Stocks, K., Unger, S., Faulkner, S., Goos, M., and Dudley, R. Randomized phase III trial of oxymetholone for the treatment of HIV wasting and lipodystrophy. Presented at the Ninh Conference on Retroviruses and Opportunistic Infections, Seattle, Wash., February 24-28, 2002.
16. Benavides, S., and Nahata, M. C. Pharmacologic therapy for HIV-associated lipodystrophy. Ann. Pharmacother. 38: 448, 2004.
17. Rietschel, P., Hadigan, C., Corcoran, C., et al. Assessment of growth hormone dynamics in human immunodeficiency virus- related lipodystrophy. J. Clin. Endocrinol. Metab. 86: 504, 2001.
18. Torres, R. A., Unger, K. W., Cadman, J. A., and Kassous, J. Y. Recombinant human growth hormone improves truncal adiposity and "buffalo humps" in HIV-positive patients on HAART (Letter). AIDS 13: 2479, 1999.
19. Wanke, C., Gerrior, J., Kantaros, J., Coakley, E., and Albrecht, M. Recombinant human growth hormone improves the fat redistribution syndrome (lipodystrophy) in patients with HIV. AIDS 13: 2099, 1999.
20. Kotler, D., Thompson, M., Grunfeld, C., et al. Growth hormone (Serostimreg) effectively reduces visceral adipose tissue (VAT) accumulation and non-HDL cholesterol. Presented at the XIVth International AIDS Conference, Barcelona, Spain, July 7-12, 2002.
21. Hadigan, C., Corcoran, C., Basgoz, N., Davis, B., Sax, P., and Grinspoon, S. Metformin in the treatment of HIV lipodystrophy syndrome: A randomized controlled trial. J.A.M.A. 284: 472, 2000.
22. Worth, L., Elliott, J., Anderson, J., Sasadeusz, J., Street, A., and Lewin, S. A cautionary tale: Fatal lactic acidosis complicating nucleoside analogue and metformin therapy (Letter). Clin. Infect. Dis. 37: 315, 2003.
23. Gelato, M. C., Mynarcik, D. C., Quick, J. L., et al. Improved insulin sensitivity and body fat distribution in HIV-infected patients treated with rosiglitazone: A pilot study. J. Acquir. Immune Defic. Syndr. 31: 163, 2002.
24. Calmy, A., Hirschel, B., Hans, D., Karsegard, V. L., and Meier, C. A. Glitazones in lipodystrophy syndrome induced by highly active antiretroviral therapy. AIDS 17: 770, 2003.
25. Mauss, S., and Schmutz, G. L-Carnitine in the treatment of HIV-associated lipodystrophy syndrome. HIV Med. 2: 59, 2001.
26. Mynarcik, D. C., Combs, T., McNurlan, M. A., Scherer, P. E., Komaroff, E., and Gelato, M. C. Adiponectin and leptin levels in HIV-infected subjects with insulin resistance and body fat redistribution. J. Acquir. Immune Defic. Syndr. 31: 514, 2002.
27. Coleman, S. R. Facial recontouring with lipostructure. Clin. Plast. Surg. 24: 347, 1997.
28. Coleman, S. R. Structural fat grafts: The ideal filler? Clin. Plast. Surg. 28: 111, 2001.
29. Coleman, S. R. Long-term survival of fat transplants: Controlled demonstrations. Aesthetic Plast. Surg. 19: 421, 1995.
30. Wolfort, F. G., Cetrulo, C. L., and Nevarre, D. R. Suction-assisted lipectomy for lipodystrophy syndromes attributed to HIV-protease inhibitor use. Plast. Reconstr. Surg. 104: 1814, 1999.
31. Ponce de Leon, S., Iglesias, M., Ceballos, J. et al. Liposuction for protease inhibitor associated lipodystrophy. Lancet 353: 1244, 1999.
32. Chastain, M. A., Chastain, J. B., and Coleman, W. P. HIV lipodystrophy: Review of the syndrome and report of a case treated with liposuction. Dermatol. Surg. 27: 497, 2001.
33. DeWeese, J., DeLaney, A., Klein, D., and Horberg, M. Surgical treatment of HIV lipohypertrophy of head and neck [abstract 721]. In Program and Abstracts of the 10th Conference on Retroviruses and Opportunistic Infections (Boston). Alexandria, Va.: Foundation for Retrovirology and Human Health, 2003. P. 316.
34. Piliero, P. L., Hubbard, M., King, J., and Faragon, J. L. Use of ultrasonography-assisted liposuction for the treatment of HIV-associated enlargement of the dorsocervical fat pad. Clin. Infect. Dis. 37: 1374, 2003.
35. Gervasoni, C., Ridolfo, A. L., Vaccarezza, M., et al. Long-term efficacy of the surgical treatment of buffalo hump in patients continuing antiretroviral therapy. AIDS 18: 574, 2004.
36. Valantin, M. A., Aubron-Olivier, C., Ghosn, J., et al. Polylactic acid implants (New-Fill) to correct facial lipoatrophy in HIVinfected patients: Results of the open-label study VEGA. AIDS 17: 2471, 2003.
37. Moyle, G. J., Lysakova, L., Brown, S., et al. A randomized open-label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection. HIV Med. 5: 82, 2004.
38. Serra-Renom, J. M., and Fontdevila, J. Treatment of facial fat atrophy related to treatment with protease inhibitors by autologous fat injection in patients with HIV infection. Plast. Reconstr. Surg. 144: 551, 2004.
39. Strauch, B., Baum, T., and Robbins, N. Treatment of HIV-associated lipodystrophy with dermafat graft transfer to the malar area. Plast. Reconstr. Surg. 113: 363, 2004.
40. Donegan, W. L., and Redlich, P. N. Breast cancer in men. Surg. Clin. North Am. 76: 343, 1996.
41. Finfer, M. D., Schinella, R. A., Rothstein, S. G., and Persky, M. S. Cystic parotid lesions in patients at risk for the acquired immunodeficiency syndrome. Arch. Otolaryngol. Head Neck Surg. 114: 1290, 1988.
42. Vaillant, J. M., Chomette, G., Talbi, M., et al. Cystic lymphoid hyperplasia of the parotid in relation to acquired immunodeficiency syndrome. Rev. Stomatol. Chir. Maxillofac. 90: 136, 1989.
43. Tunkel, D. E., Loury, M. C., Fox, C. H., Goins, M. A., III, and Johns, M. E. Bilateral parotid enlargement in HIV-seropositive patients. Laryngoscope 99: 590, 1989.
44. Huang, R. D., Pearlman, S., Friedman, W. H., and Loree, T. Benign cystic vs. solid lesions of the parotid gland in HIV patients. Head Neck 13: 522, 1991.
45. Nitzan, D., Kronenberg, J., Horowitz, Z., et al. Quality of life following parotidectomy for malignant and benign disease. Plast. Reconstr. Surg. 114: 1060, 2004.
46. Singer, D. P., and Sullivan, P. K. Submandibular gland I: An anatomic evaluation and surgical approach to submandibular gland resection for facial rejuvenation. Plast. Reconstr. Surg. 112: 1150, 2003.
47. Marten, T. J. Submandibular gland resection in rejuvenation of the aging face. Course hand-out from the American Society for Aesthetic Plastic Surgery, May 2005.
48. dePina, D. P., and Quinta, W. C. Aesthetic resection of the submandibular salivary gland. Plast. Reconstr. Surg. 5: 779, 1991.
49. Adams, J. R., and Kawamoto, H. K. Late infection following aesthetic malar augmentation with proplast implants. Plast. Reconstr. Surg. 95: 382, 1995.
50. Williams, C. W. Malar implant infections resulting from recurrent infections of adjacent dental pathology. Plast. Reconstr. Surg. 93: 1533, 1994.
51. Wilkinson, T. S. Complications in aesthetic malar augmentation. Plast. Reconstr. Surg. 71: 643, 1983.
52. Talmor, M., Hoffman, L., and LaTrenta, G. Facial atrophy in HIV-related fat redistribution syndrome: Anatomic evaluation and surgical reconstruction. Ann. Plast. Surg. 49: 11, 2002.